These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 2875864

  • 1. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
    Campoli-Richards DM, Clissold SP.
    Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
    [Abstract] [Full Text] [Related]

  • 2. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.
    Langtry HD, Grant SM, Goa KL.
    Drugs; 1989 Oct; 38(4):551-90. PubMed ID: 2573505
    [Abstract] [Full Text] [Related]

  • 3. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR, Tankanow RM, Nostrant TT.
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [Abstract] [Full Text] [Related]

  • 4. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
    Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS.
    Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216
    [Abstract] [Full Text] [Related]

  • 5. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP, Campoli-Richards DM.
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [Abstract] [Full Text] [Related]

  • 6. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology.
    Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885
    [Abstract] [Full Text] [Related]

  • 7. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
    Howard JM, Chremos AN, Collen MJ, McArthur KE, Cherner JA, Maton PN, Ciarleglio CA, Cornelius MJ, Gardner JD, Jensen RT.
    Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
    [Abstract] [Full Text] [Related]

  • 8. Famotidine: effective treatment of Zollinger-Ellison syndrome.
    Howard JM, Vinayek R, Maton PN, Wank SA, Gardner JD, Jensen RT.
    J Clin Gastroenterol; 1987 Apr; 9 Suppl 2():23-5. PubMed ID: 2887615
    [Abstract] [Full Text] [Related]

  • 9. Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Price AH, Brogden RN.
    Drugs; 1988 Nov; 36(5):521-39. PubMed ID: 2905640
    [Abstract] [Full Text] [Related]

  • 10. Famotidine in the therapy of gastric hypersecretory states.
    Vinayek R, Howard JM, Maton PN, Wank SA, Slaff JI, Gardner JD, Jensen RT.
    Am J Med; 1986 Oct 24; 81(4B):49-59. PubMed ID: 2877575
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB, Faulds D, McTavish D.
    Drugs; 1992 Aug 24; 44(2):225-50. PubMed ID: 1382017
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Thomson AB, Mahachai V.
    Clin Invest Med; 1987 May 24; 10(3):152-70. PubMed ID: 2887321
    [Abstract] [Full Text] [Related]

  • 14. Medical treatment of peptic ulcers.
    Deveney CW, Deveney KE.
    Surg Annu; 1985 May 24; 17():219-33. PubMed ID: 3883541
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W.
    J Int Med Res; 1989 May 24; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [Abstract] [Full Text] [Related]

  • 18. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Maton PN, Gardner JD, Jensen RT.
    Gastroenterol Clin North Am; 1989 Dec 24; 18(4):847-63. PubMed ID: 2575602
    [Abstract] [Full Text] [Related]

  • 19. Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.
    Carmine AA, Brogden RN.
    Drugs; 1985 Aug 24; 30(2):85-126. PubMed ID: 3928324
    [Abstract] [Full Text] [Related]

  • 20. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
    Bianchi Porro G.
    Digestion; 1985 Aug 24; 32 Suppl 1():62-9. PubMed ID: 2866137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.